Dr. Reddy’s is launching doxercalciferol injection, in 4 mcg/2 mL multidose vials. The product is the generic of Sanofi-Aventis’ Hectorol (doxercalciferol) injection 4 mcg/2 mL (2 mcg/mL) ...
Doxercalciferol 2mcg/mL; soln for IV inj. Give by IV bolus inj. Dialysis: initially 4mcg three times weekly after dialysis; titrate dose to maintain desired iPTH therapeutic range and serum calcium ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
Dr. Reddy’s Laboratories (NYSE:RDY) has launched Doxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, the therapeutic generic equivalent of Sanofi-Aventis' Hectorol (doxercalciferol) ...
WILMINGTON, Del., May 25 (Reuters) - Genzyme Corp has sued Sandoz Inc, accusing it of infringing the patent for its Hectorol drug which is approved for controlling hormone production in patients with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback